Flow mediated dilation of the brachial artery: an investigation of methods requiring further standardizationBMC Cardiovascular Disorders - Tập 7 Số 1 - 2007
Alon Peretz, Daniel F. Leotta, Jeffrey Sullivan, Carol A. Trenga, Fiona N. Sands, M. Aulet, Marla Paun, Edward A. Gill, Joel D. Kaufman
Abstract
Background
In order to establish a consistent method for brachial artery reactivity assessment, we analyzed commonly used approaches to the test and their effects on the magnitude and time-course of flow mediated dilation (FMD), and on test variability and repeatability. As a popular and...... hiện toàn bộ
A cross-sectional analysis of the relationship between uric acid and coronary atherosclerosis in patients with suspected coronary artery disease in ChinaBMC Cardiovascular Disorders - Tập 14 Số 1 - 2014
Yujiao Sun, Xin Yu, Yi Zhi, Geng Song, Hua Li, Ting Liu, Ke Xu, Ling Chen, Wu Chunwei, Guoxian Qi
AbstractBackgroundAlthough many studies have examined the relationship between uric acid (UA) and coronary artery disease (CAD), whether UA is an independent risk factor contributing to progression of CAD is still controversial. Whether UA plays a different role in different sexes is also unclear.... hiện toàn bộ
Effects of care pathways on the in-hospital treatment of heart failure: a systematic reviewBMC Cardiovascular Disorders - Tập 12 - Trang 1-9 - 2012
Seval Kul, Antonella Barbieri, Erika Milan, Ilke Montag, Kris Vanhaecht, Massimiliano Panella
Care pathways have become a popular tool to enhance the quality of care by improving patient outcomes, promoting patient safety, increasing patient satisfaction, and optimizing the use of resources. We performed a disease specific systematic review to determine how care pathways in the hospital treatment of heart failure affect in-hospital mortality, length of in-hospital stay, readmission rate an...... hiện toàn bộ
Efficacy of team-based collaborative care for distressed patients in secondary prevention of chronic coronary heart disease (TEACH): study protocol of a multicenter randomized controlled trialBMC Cardiovascular Disorders - - 2020
Christoph Herrmann‐Lingen, Christian Albus, Martina de Zwaan, Franziska Geiser, Katrin Heinemann, Martin Hellmich, Matthias Michal, Monika Sadlonova, Ralf Tostmann, Rolf Wachter, Bea Herbeck Belnap
Abstract
Background
Coronary heart disease (CHD) is the leading cause of death and years of life lost worldwide. While effective treatments are available for both acute and chronic disease stages there are unmet needs for effective interventions to support patients in health behaviors required for s...... hiện toàn bộ
Comprehensive analysis of T-cell receptor repertoire in patients with acute coronary syndrome by high-throughput sequencingBMC Cardiovascular Disorders - Tập 20 - Trang 1-9 - 2020
Sudong Liu, Zhixiong Zhong, Wei Zhong, Ruiqiang Weng, Jing Liu, Xiaodong Gu, Yongyu Chen
This study aims to investigate the T-cell receptor (TCR) repertoire in patients with acute coronary syndrome (ACS). The TCR repertoires of 9 unstable angina patients (UA), 14 acute myocardial infarction patients (AMI) and 9 normal coronary artery (NCA) patients were profiled using high-throughput sequencing (HTS). The clonal diversity of the TCR repertoires in different groups was analyzed, as wel...... hiện toàn bộ
Tolvaptan-induced hypernatremia related to low serum potassium level accompanying high blood pressure in patients with acute decompensated heart failureBMC Cardiovascular Disorders - Tập 20 - Trang 1-7 - 2020
Hidetada Fukuoka, Koichi Tachibana, Yukinori Shinoda, Tomoko Minamisaka, Hirooki Inui, Keisuke Ueno, Soki Inoue, Kentaro Mine, Kumpei Ueda, Shiro Hoshida
Tolvaptan significantly increases urine volume in acute decompensated heart failure (ADHF); serum sodium level increases due to aquaresis in almost all cases. We aimed to elucidate clinical factors associated with hypernatremia in ADHF patients treated with tolvaptan. We enrolled 117 ADHF patients treated with tolvaptan in addition to standard therapy. We examined differences in clinical factors a...... hiện toàn bộ
Influence of smoking cessation drugs on blood pressure and heart rate in patients with cardiovascular disease or high risk score: real life settingBMC Cardiovascular Disorders - Tập 16 - Trang 1-6 - 2016
André Pacheco Silva, Jaqueline Scholz, Tania Ogawa Abe, Gabriela Gouveia Pinheiro, Patricia Viviane Gaya, Alexandre Costa Pereira, Paulo Caleb Junior Lima Santos
Smoking is the most important reversible cardiovascular risk factor. It is well established that quitting smoking reduces coronary events. However, on several occasions, the cardiovascular safety of smoking cessation drugs has been questioned. Our goal is to evaluate the effects of smoking cessation drugs on blood pressure and heart rate in patients from a smoking cessation service in a cardiology...... hiện toàn bộ